Filing Details
- Accession Number:
- 0001209191-20-042492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 16:51:49
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-15 16:51:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-07-13 | 860 | $90.29 | 15,792 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $284.56 | 15,692 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 60 | $285.71 | 15,632 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $287.86 | 15,532 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 50 | $291.97 | 15,482 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 200 | $294.18 | 15,282 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 250 | $294.99 | 15,032 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-07-13 | 100 | $295.78 | 14,932 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2020-07-13 | 860 | $0.00 | 860 | $90.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-07-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $284.56 (range $284.37 to $284.74).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $285.71 (range $285.59 to $285.83).
- Open market sales reported on this line occurred at a weighted average price of $287.86 (range $287.85 to $287.86).
- Open market sales reported on this line occurred at a weighted average price of $294.18 (range $293.67 to $294.39).
- Open market sales reported on this line occurred at a weighted average price of $294.99 (range $294.68 to $295.42).
- Open market sales reported on this line occurred at a weighted average price of $295.78 (range $295.75 to $295.80).
- Fully vested.
Billionaire Hedge Funds
